Thyroid hormone stimulates osteoclast differentiation by a mechanism independent of RANKL-RANK interaction
- PMID: 15281085
- DOI: 10.1002/jcp.20041
Thyroid hormone stimulates osteoclast differentiation by a mechanism independent of RANKL-RANK interaction
Abstract
It is well known that thyroid hormone excess causes bone loss. However, the precise mechanism of bone loss by thyroid hormone still remains unclear. When T(3) was added to unfractionated bone cells after degeneration of pre-existent osteoclasts, T(3) (1 pM-100 nM) dose-dependently stimulated osteoclast-like cell formation, irrespective of the presence of indomethacin and IL-6 Ab. T(3) increased the expression of osteoprotegerin (OPG) messenger RNA (mRNA), but not of receptor activator of nuclear factor kappaB ligand (RANKL) in unfractionated bone cells, suggesting that the stimulatory effect of T(3) on osteoclast formation was not mediated by the RANKL/OPG system. We next examined the direct effect of T(3) on osteoclast precursors in the absence of osteoblasts, using hemopoietic blast cells derived from spleen cells. T(3) (1 pM-100 nM) dose-dependently stimulated osteoclast-like cell formation from osteoclast precursors. OPG did not inhibit T(3)-induced osteoclast formation from osteoclast precursor cells. The polymerase chain reaction (PCR) product corresponding in size to the mouse T(3) receptor alpha1 cDNA was detected in osteoclast precursors from mouse hemopoietic blast cells as well as mouse heart and mouse osteoblastic cell line MC3T3-E1 cells, suggesting that T(3) directly stimulated osteoclast-like cell formation from osteoclast precursors in the absence of osteoblasts. Further, T(3) increased the expression of c-Fos mRNA at 15 min and 24 h and Fra-1 mRNA at 2 and 6 h in osteoclast precursors. Consistent with the increased expression of c-Fos mRNA observed by RT-PCR, the activation of c-Fos occurred in osteoclast precursor cells stimulated by T(3), while the activation of neither NF-kappaB nor MAPKs was observed by immunoblot analysis. Antisense oligodeoxynucleotides (as-ODN) complementary to c-Fos mRNA at 1 microM significantly inhibited T(3)-induced osteoclast-like cell formation from osteoclast precursors in the absence of stromal cells while sense-ODN did not affect T(3)-induced osteoclast-like cell formation. These results indicate that T(3) directly stimulates osteoclast differentiation at least in part by up-regulation of c-fos protein in osteoclast precursor cells.
Similar articles
-
Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity.J Cell Physiol. 2003 Jul;196(1):180-9. doi: 10.1002/jcp.10270. J Cell Physiol. 2003. PMID: 12767054
-
Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions.J Bone Miner Res. 2001 Oct;16(10):1787-94. doi: 10.1359/jbmr.2001.16.10.1787. J Bone Miner Res. 2001. PMID: 11585342
-
Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.J Bone Miner Res. 2000 Aug;15(8):1459-66. doi: 10.1359/jbmr.2000.15.8.1459. J Bone Miner Res. 2000. PMID: 10934644
-
A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function.Biochem Biophys Res Commun. 1999 Mar 24;256(3):449-55. doi: 10.1006/bbrc.1999.0252. Biochem Biophys Res Commun. 1999. PMID: 10080918 Review.
-
Osteoprotegerin and its ligand: A new paradigm for regulation of osteoclastogenesis and bone resorption.Medscape Womens Health. 2000 Mar;5(2):5. Medscape Womens Health. 2000. PMID: 10792853 Review.
Cited by
-
Physiological Bone Remodeling: Systemic Regulation and Growth Factor Involvement.Physiology (Bethesda). 2016 May;31(3):233-45. doi: 10.1152/physiol.00061.2014. Physiology (Bethesda). 2016. PMID: 27053737 Free PMC article. Review.
-
The role of IL-6 and osteoprotegerin in bone metabolism in patients with Graves' disease.Turk J Med Sci. 2022 Apr;52(2):338-345. doi: 10.55730/1300-0144.5320. Epub 2022 Apr 14. Turk J Med Sci. 2022. PMID: 36161625 Free PMC article.
-
Role of thyroid hormones in craniofacial development.Nat Rev Endocrinol. 2020 Mar;16(3):147-164. doi: 10.1038/s41574-019-0304-5. Epub 2020 Jan 23. Nat Rev Endocrinol. 2020. PMID: 31974498 Review.
-
Transcriptomic profiling of feline teeth highlights the role of matrix metalloproteinase 9 (MMP9) in tooth resorption.Sci Rep. 2020 Nov 3;10(1):18958. doi: 10.1038/s41598-020-75998-3. Sci Rep. 2020. PMID: 33144645 Free PMC article.
-
Endocrine Regulation on Bone by Thyroid.Front Endocrinol (Lausanne). 2022 Apr 5;13:873820. doi: 10.3389/fendo.2022.873820. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35464058 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials